Covered recipient · General Payments record
CHELSEA L MCNUTT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,037.16
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.45 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $146.93 | 3 |
| ABBVIE INC. | $34.37 | 1 |
| Acerta Pharma LLC | $34.22 | 2 |
| Amgen Inc. | $30.56 | 2 |
| Exact Sciences Corporation | $26.61 | 1 |
| Lilly USA, LLC | $16.49 | 1 |
| PFIZER INC. | $16.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.37 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107642316 | CMS |
| Amgen Inc. | $16.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115922013 | CMS |
| Amgen Inc. | $14.13 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115922018 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.80 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104197673 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.42 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105574224 | CMS |
| Exact Sciences Corporation | $26.61 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114497130 | CMS |
| Lilly USA, LLC | $16.49 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135556458 | CMS |
| Novo Nordisk Inc | $16.65 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100339278 | CMS |
| Novo Nordisk Inc | $125.00 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100412571 | CMS |
| Novo Nordisk Inc | $5.28 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100459622 | CMS |
| PFIZER INC. | $16.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131826803 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.